Ovarian cancer is the deadliest gynecologic malignancy globally and is increasing in incidence and mortality with currently ...

However, researchers at the Penn Ovarian Cancer Research Center at the University of Pennsylvania are studying a surprising ...

Researchers at Peter Mac have uncovered potential new heredity genes that might be responsible for causing one of the most ...

While genetic testing rates for advanced ovarian cancer have increased, gaps in physician understanding and confidence in interpreting results may limit optimal biomarker-driven treatment and patient ...

Ovarian cancer, a deadly gynecologic malignancy, has seen a significant shift in its treatment paradigm with the introduction of poly (ADP-ribose ...

Ovarian cancer, a deadly gynecologic malignancy, has seen a significant shift in its treatment paradigm with the introduction ...

As a result, current treatment approaches are often based on the more common high-grade serous ovarian carcinoma (HGSOC).

A group of researchers in China have looked into the role of apolipoprotein B100 (ApoB100) in ovarian cancer following reports of excessive levels of ApoB100 inducing endoplasmic reticulum stress and ...

There are currently no FDA-approved treatments specifically for LGSOC, a rare and distinct ovarian cancer that differs from high-grade serous ovarian cancer in both its biology and how it responds ...